Hormonal contraceptive use, particularly OCPs, does not appear to reduce ACL injury risk in females. Given the potential side effects of HC and the lack of conclusive benefit, clinicians should not recommend HC use solely for injury prevention. Future research should focus on non-OCP preventive strategies for ACL injury, diverse athletic populations, and standardized reporting of HC formulations.
No takes yet. Share an insight, caveat, or question.
Paška et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: